Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomerica

3.11
-0.0400-1.27%
Post-market: 3.110.00000.00%16:53 EDT
Volume:20.40K
Turnover:62.97K
Market Cap:7.92M
PE:-1.45
High:3.24
Open:3.10
Low:3.07
Close:3.15
52wk High:10.16
52wk Low:2.08
Shares:2.55M
Float Shares:2.38M
Volume Ratio:0.39
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1422
EPS(LYR):-2.8430
ROE:-72.70%
ROA:-35.99%
PB:1.43
PE(LYR):-1.09

Loading ...

Biomerica Inc. Unveils Investor Presentation Highlighting Diagnostic Innovations and Personalized Therapies

Reuters
·
Jul 17

Biomerica announces inFoods IBS received CPT PLA code

TIPRANKS
·
Jul 02

Press Release: Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer

Dow Jones
·
Jun 26

Press Release: Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Dow Jones
·
Jun 06

BRIEF-United Arab Emirates Ministry Of Health And Prevention Approves Biomerica’S Fortel® Ulcer Test For Detection Of H. Pylori Infection

Reuters
·
Apr 23

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection

GlobeNewswire
·
Apr 23

Biomerica Third Quarter 2025 Earnings: US$0.061 loss per share (vs US$0.11 loss in 3Q 2024)

Simply Wall St.
·
Apr 18

Biomerica Inc trading halted, news pending

TIPRANKS
·
Apr 18

BRIEF-Biomerica - Fortel Kidney Disease Test Approved For Sale In UAE

Reuters
·
Apr 17

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage

GlobeNewswire
·
Apr 17

Biomerica Plans Reverse Stock Split to Regain Nasdaq Listing Compliance

MT Newswires Live
·
Apr 16

Biomerica Announces Reverse Stock Split

Reuters
·
Apr 16

BRIEF-Biomerica Reports Third Quarter Fiscal 2025 Financial Results

Reuters
·
Apr 15

Biomerica Q3 EPS $(0.06) Up From $(0.11) YoY, Sales $1.12M Up From $1.02M YoY

Benzinga
·
Apr 15

Press Release: Biomerica Reports Third Quarter Fiscal 2025 Financial Results

Dow Jones
·
Apr 15

Biomerica achieves IVDR certification in European union

TIPRANKS
·
Feb 26

Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn’s Disease and Ulcerative Colitis

GlobeNewswire
·
Feb 26

BRIEF-Biomerica’S Infoods® IBS Clinical Trial Results Published And Featured In Gastroenterology, The Leading Gi Medical Journal

Reuters
·
Feb 19

Biomerica’s inFoods® IBS Clinical Trial Results Published and Featured in Gastroenterology, the Leading GI Medical Journal

GlobeNewswire
·
Feb 19